APP Pharmaceuticals

APP Pharmaceuticals is a professional pharmaceutical company that integrates the research, production, and sales of injectable drugs. We currently produce more than 100 non-patented injectable products, with over 300 different dosage forms and formulations.Their main focus is on the oncology, anti-infective, and critical care markets, where they believe they offer one of the most comprehensive portfolios of generic injectable products in these therapeutic categories. They have obtained the license for ABI-007, a patented formulation of paclitaxel, which is a proprietary injectable oncology candidate.